News
AKTUELLE NACHRICHTEN ÜBER UNSERE GRUPPE
MTD Group completes strategic brand divestiture, accelerating focus on drug delivery innovation
Industrial operations across Europe continue to support global partners with high-performance medical solutions Milan, 12 December 2025 – MTD Group has finalized the sale of
MTD Group achieves first EcoVadis Assessment and receives the “Committed” Badge
MTD Group is proud to announce that it has successfully completed its first sustainability assessment with EcoVadis, a globally recognized platform for evaluating companies’ environmental,
MTD Group completes the acquisition of Ypsomed’s Pen Needles and Blood Glucose Monitoring Systems and announces a significant investment plan for its European production sites
Milan, August 2nd, 2024 – Medical Technology and Devices (MTD) is pleased to announce the successful closing of the acquisition of Ypsomed’s Pen Needles and
MTD has joined the United Nations Global Compact initiative
The MTD Group is pleased to announce that it has joined the United Nations Global Compact initiative, one of the world’s largest corporate sustainability programs,
MTD acquires Ypsomed’s pen needle and BGM businesses, strengthening its leading position in diabetes care
Milan, 27 March 2024 – MTD (Medical Technology and Devices), a leading provider of medical technology solutions for self-care and professional use worldwide, announces the
Safe and effective use of a passive safety needle by healthcare professionals in a simulated environment, including perceptions and preferences
2023 – Needlestick injuries (NSIs) may potentially expose healthcare professionals (HCPs) to bloodborne pathogens. Safety needles are designed to protect against NSIs. We evaluated whether